The Rebound Pain
Conditions
Interventions
Group IV:0.25% Ropivacaine + normal saline totaling 20ml for Brachial Plexus Block 5mg (1ml) Dexamethasone intravenous injection
Group PN:0.25% Ropivacaine + 5mg (1ml) Dexamethasone totaling 20ml for Brachial Plexus Block 1ml Normal saline intravenous injection
Sponsors
The First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Signing of the informed consent form. 2. Classification I-II by the American Society of Anesthesiologists (ASA); 3. Planned elective repair surgery for shoulder cuff injury.
Exclusion criteria
Exclusion criteria: 1. Allergy to the drugs used in this study 2. Coagulation dysfunction 3. History of previous shoulder and chest surgery, or peripheral neuropathy caused by spine and upper limb diseases 4. History of long-term opioid use, or history of alcohol and drug addiction 5. Combined with severe heart, liver, kidney and other organ insufficiency 6. Diabetic patients 7. Those who cannot cooperate with the numerical rating scale (NRS) test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the incidence of rebound pain;NRS score; | — |
Countries
China
Contacts
Public ContactCheng Hao
The First Affiliated Hospital of Soochow University
Outcome results
None listed